Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To evaluate the impact of clinical pharmacist-led discharge education service in patients with acute coronary syndrome.
This prospective, randomized controlled study was conducted in patients with acute coronary syndrome in an cardiology service of tertiary training and research hospital. The clinical pharmacist, within the scope of the discharge education services, provided medication reconciliation, medication review, individually prepared patient medicine (pill) card, patient education (based on Health Belief Model by using written material and video, and verbally [by using Teach back method especially for patients with low health literacy]) and counseling (using behavior change techniques based on The Capability, Opportunity, and Motivation Behavior model). The control group received standard care.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Clinical Pharmacist-led discharge education program | Experimental | Clinical pharmacist-led services |
|
| Control group | No Intervention | Usual care |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Discharge Education Program | Behavioral | medication reconciliation, medication review, individually prepared patient medicine (pill) card, patient education (based on Health Belief Model by using written material and video, and verbally [by using Teach back method especially for patients with low health literacy]) and counseling (using behavior change techniques based on The Capability, Opportunity, and Motivation Behavior model). |
| Measure | Description | Time Frame |
|---|---|---|
| 30 days hospital re-admission for cardiac reasons | Proportion of patients readmitted to hospital for cardiac cause at 1 month | 30 days |
| Measure | Description | Time Frame |
|---|---|---|
| Hospital re-admission for cardiac reasons | Proportion of patients readmitted to hospital for cardiac cause through 1 year. | 3 months, 6 months, and 12 months |
| Hospital re-admission for any reasons |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Betul Okuyan | Marmara University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Marmara University | Istanbul | Turkey (Türkiye) |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 41945242 | Derived | Demirci MY, Mutlu B, Sancar M, Okuyan B. Impact of clinical pharmacist-led behavioural theory-based discharge service to promote medication adherence in patients with acute coronary syndrome: a randomised controlled trial. Int J Clin Pharm. 2026 Apr 7. doi: 10.1007/s11096-026-02134-y. Online ahead of print. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D054058 | Acute Coronary Syndrome |
| ID | Term |
|---|---|
| D017202 | Myocardial Ischemia |
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
| D014652 | Vascular Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
Proportion of patients readmitted to hospital for any cause through 1 year.
| 1 month, 3 months, 6 months, and 12 months |
| Emergency service visits | Proportion of patients visited to emergency service through 1 year. | 1 month, 3 months, 6 months, and 12 months |
| Major Adverse Cardiovascular Event | Proportion of patients had major adverse cardiovascular event through 1 year. | 1 month, 3 months, 6 months, and 12 months |
| Death for cardiac reason | Proportion of patients died for cardiac cause through 1 year. | 1 month, 3 months, 6 months, and 12 months |
| Death for any reason | Proportion of patients dying for any cause through 1 year. | 1 month, 3 months, 6 months, and 12 months |
| Medication Adherence | Adherence to Cardioprotective Medications (Clopidogrel, Statins, Beta-blockers, Angiotensin-converting enzyme (ACE) inhibitors/ Angiotensin receptor blocker (ARB) through 1 year assessed by Medication Adherence Report Scale (MARS). MARS assesses adherence through 5-item, summed to give a scale score ranging from 5 to 25, where higher scores indicate higher levels of reported adherence. | 1 month, 3 months, 6 months, and 12 months |
| Quality of Life Measurement | Change in quality of life from baseline assessed with EuroQol questionnaire EQ-5D-3L through 1 year. (EQ-5D-3L) is a standardized scale for use as a measure of the quality of life. The EQ-5D-3L descriptive system comprises the following 5 dimensions (5D): mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has 3 levels (3L): no problems (1 point), some problems (2 points), extreme problems (3 points). This gives a total of 245 different health states, adding unconscious and dead. | 1 month, 3 months, 6 months, and 12 months |
| Achieved Target Low-density Lipoprotein Value | Rate of patients achieved target low-density lipoprotein value | 6 months, 12 months |